Finance

Beta
Lists
BVS:NASDAQ
Bioventus Inc
$9.04
0.00%
(0.00) 1D
Jun 8, 12:11:21 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BVS...
Open
$9.03
High
$9.19
Low
$8.97
Mkt. cap
612.44M
Avg. vol.
640.73K
Volume
224.78K
52-wk high
$11.25
52-wk low
$5.81
Beta
0.67
Shares outstanding
67.75M
No. of employees
940
Open
$9.03
High
$9.19
Low
$8.97
Mkt. cap
612.44M
Avg. vol.
640.73K
Volume
224.78K
52-wk high
$11.25
52-wk low
$5.81
Beta
0.67
Shares outstanding
67.75M
No. of employees
940
Analyst outlook
Analyst Ratings
Based on 4 analysts giving stock ratings to BVS in the past 3 months
Strong Buy
Buy
4
Hold
0
Sell
0
12 month forecast
Based on 4 Wall Street analysts offering 12 month price targets for BVS in the last 3 months.
Highest
Current $9.04
$15.00 (+65.93%)
Average
$14.33 (+58.52%)
Lowest
$14.00 (+54.87%)
News stories
From sources across the web
About Bioventus Inc
CEO-
Employees940
Founded2011
Headquarters-
SectorMedical device
Websitebioventus.com
Last report
May 6, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.15 / $0.07
+120.59%beat
Revenue / Est. (USD)
132.09M / 129.90M
+1.69%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
147.66M
138.65M
157.90M
132.09M
Cost of goods sold
45.57M
44.42M
49.12M
41.32M
Cost of revenue
45.57M
44.42M
49.12M
41.32M
Research and development expenses
3.17M
2.92M
3.01M
2.47M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
79.10M
78.64M
82.76M
78.31M
Operating expense
83.71M
82.96M
87.06M
81.88M
Total operating expenses
129.28M
127.39M
136.18M
123.20M
Operating income
18.38M
11.26M
21.72M
8.89M
Other non operating income
-561.00K
-79.00K
-2.01M
427.00K
EBT including unusual items
10.31M
4.67M
14.14M
4.52M
EBT excluding unusual items
10.33M
5.01M
16.38M
4.99M
Income tax expense
1.04M
664.00K
-3.18M
571.00K
Effective tax rate
10.09%
14.22%
-22.45%
12.64%
Other operating expenses
-
-
-
-
Net income
7.46M
3.16M
14.76M
3.11M
Net profit margin
5.05%
2.28%
9.34%
2.36%
Earnings per share
0.21
0.15
0.24
0.15
Interest and investment income
-
-
-
-
Interest expense
-7.49M
-6.18M
-5.31M
-4.33M
Net interest expenses
-7.49M
-6.18M
-5.31M
-4.33M
Depreciation and amortization charges
1.44M
1.40M
1.30M
1.11M
EBITDA
30.43M
22.67M
27.05M
20.09M
Gain or loss from assets sale
1.00K
-1.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer